Cancer versus heart failure patient self-declared potential interest in clinical trials Maurie MarkmanLarie SmoyerRobert Montgomery Editor’s Commentary Pages: 1 - 5
The use of HER2 modulation in the adjuvant setting Peter H. JohnsonFrancisco J. Esteva OriginalPaper Pages: 9 - 16
Impact on quality of life of adjuvant therapy for breast cancer Halle C. F. Moore OriginalPaper Pages: 42 - 46
Designing clinical trials for brain tumors: The next generation Mark R. Gilbert OriginalPaper Pages: 49 - 54
Net clinical benefit: Functional endpoints in brain tumor clinical trials Terri S. ArmstrongMark R. Gilbert OriginalPaper Pages: 60 - 65
Therapeutic advances for glioblastoma multiforme: Current status and future prospects H. Ian RobinsSusan ChangMinesh Mehta OriginalPaper Pages: 66 - 70
Impact of molecular profiling on clinical trial design for glioblastoma Arnab ChakravartiErin TyndallJay Loeffler OriginalPaper Pages: 71 - 79